Corindus has been rebranded to Siemens Healthineers Endovascular Robotics and will sit as a dedicated business within the Advanced Therapies area of Siemens Healthineers, the company has announced.
This brand unification is the final step of the company integration process that commenced in 2019 with the acquisition of Corindus by Siemens Healthineers, the company says in a press release. The aim of the Endovascular Robotics business is to advance interventions with robotics and change the way that care is delivered through innovations that enhance physician technique and bring precision to interventional procedures, the press release adds.
Siemens Healthineers Endovascular Robotics says it will continue to offer the CorPath GRX system to support endovascular procedures while working to revolutionise treatment of emergent conditions by developing technologies to provide specialised and timely medical care to more patients around the world.
Wayne Markowitz, worldwide executive vice president of Siemens Healthineers and head of endovascular robotics, said: “The completion of our brand evolution marks the final step to becoming a united company and we remain focused on pioneering breakthroughs for everyone, everywhere. Our flagship product, the CorPath GRX system, is designed to support endovascular interventions, and we look forward to working with our customers as Siemens Healthineers Endovascular Robotics while fuelling our vision to connect more patients to advanced care.”
Source CardiovascularNews
Duc Tin Clinic
Tin tức liên quan
Performance diagnostique de l’interféron gamma dans l’identification de l’origine tuberculeuse des pleurésies exsudatives
A Mixed Phenotype of Airway Wall Thickening and Emphysema Is Associated with Dyspnea and Hospitalization for Chronic Obstructive Pulmonary Disease.
Radiological Approach to Asthma and COPD-The Role of Computed Tomography.
Significant annual cost savings found with UrgoStart in UK and Germany
Thrombolex announces 510(k) clearance of Bashir catheter systems for thromboembolic disorders
Phone: (028) 3981 2678
Mobile: 0903 839 878 - 0909 384 389